Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Shares withheld for taxes EVP, Chief Strat & Dev Officer gave up 2,051 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,396 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, Business Operations gave up 1,964 shares (to pay taxes)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change · Regulation FD disclosure
  10. 8-K Event Regulation FD disclosure
  11. 4 Grant or award EVP, Quality & Ethics, and CPL acquired 96,310 shares (grant or award)
  12. 4 Grant or award EVP, Ext Aff, GC, Corp Sec acquired 56,180 shares (grant or award)
  13. 8-K Event Regulation FD disclosure
  14. 4 Open-market sale Director sold 1,912 shares at $11.94 ($22,829)
  15. 4 Shares withheld for taxes EVP, Ext Aff, GC, Corp Sec gave up 416 shares (to pay taxes)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. 8-K Event Acquisition or sale completed · Regulation FD disclosure
  19. 8-K Event Other events
  20. 8-K/A Event Results of operations · Regulation FD disclosure

Page 19 of 87 · 1,733 filings